Zynaxis, Hoechst AG deal

Hoechst will evaluate the ability of ZNXS's Zyn-Linker molecules to enhance delivery of Hoechst's oligonucleotides. Hoechst learned about the Zyn-Lynker technology through a mutual partner, Aronex Ph...